265 related articles for article (PubMed ID: 10583306)
1. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man.
Pinto AC; Finamor FE; Lengyel AM
Clin Endocrinol (Oxf); 1999 Oct; 51(4):409-14. PubMed ID: 10583306
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
[TBL] [Abstract][Full Text] [Related]
3. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism.
Pimentel-Filho FR; Ramos-Dias JC; Ninno FB; Façanha CF; Liberman B; Lengyel AM
Clin Endocrinol (Oxf); 1997 Mar; 46(3):295-300. PubMed ID: 9156038
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.
Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
[TBL] [Abstract][Full Text] [Related]
7. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
Borges MH; DiNinno FB; Lengyel AM
Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
[TBL] [Abstract][Full Text] [Related]
9. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
10. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism.
Ramos-Dias JC; Pimentel-Filho F; Reis AF; Lengyel AM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1343-6. PubMed ID: 8636330
[TBL] [Abstract][Full Text] [Related]
11. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
Villas-Boas Weffort RF; Ramos-Dias JC; Chipoch C; Lengyel AM
Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
15. Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Nascif SO; Senger MH; Ramos-Dias JC; Lengyel AM
J Endocrinol Invest; 2003 Aug; 26(8):733-7. PubMed ID: 14669827
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
[TBL] [Abstract][Full Text] [Related]
17. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
[TBL] [Abstract][Full Text] [Related]
19. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
[TBL] [Abstract][Full Text] [Related]
20. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
